Supernus Pharmaceuticals, Inc.

Patent Owner

Compare Create Portfolio
1Status Updates

Stats

Details

Technologies

Intl Class Technology # of Patents/ App Rank in Class
 
 
 
A61K PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES 64182
 
 
 
A61P THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS 874
 
 
 
A01N PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF 285
 
 
 
C12N MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF 2150
 
 
 
A61F FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, E.G. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS 1128
 
 
 
B65B MACHINES, APPARATUS OR DEVICES FOR, OR METHODS OF, PACKAGING ARTICLES OR MATERIALS; UNPACKING 160
 
 
 
C07C ACYCLIC OR CARBOCYCLIC COMPOUNDS 1124
 
 
 
C07D HETEROCYCLIC COMPOUNDS 1142

Top Patents (by citation)

Upgrade to the Premium Level to View Top Patents for this Owner. Learn More

Recent Publications

Publication # Title Filing Date Pub Date Intl Class
2014/0303,252 OSMOTIC DRUG DELIVERY SYSTEMApr 30, 14Oct 09, 14[A61K]
2014/0187,552 METHOD OF TREATMENT OF AGGRESSIONJul 26, 13Jul 03, 14[A61K]
2014/0135,326 METHOD OF TREATMENT OF AGGRESSIONNov 13, 13May 15, 14[A61K]
2013/0202,661 FORMULATIONS OF VILOXAZINEFeb 07, 13Aug 08, 13[A61K]
2013/0011,483 FORMULATIONS OF MAZINDOLMar 30, 11Jan 10, 13[A61P, A61K]
2012/0302,615 METHOD OF TREATMENT OF CNS DISORDERSDec 02, 10Nov 29, 12[A61P, A61K]
2012/0115,871 METHOD OF TREATMENT OF DEPRESSIONApr 29, 10May 10, 12[A61P, A61K]
2011/0251,198 METHODS FOR PRODUCING VILOXAZINE SALTS AND NOVEL POLYMORPHS THEREOFApr 12, 11Oct 13, 11[C07D, A61P, C07C, A61K]
2009/0304,794 CONTROLLED RELEASE FORMULATIONS OF PRAMIPEXOLEJun 05, 09Dec 10, 09[A61P, A61K]
2009/0280,176 CONTROLLED RELEASE FORMULATIONS OF ALPRAZOLAMMay 07, 09Nov 12, 09[A61P, A61K]

View all Publication..

Recent Patents

Patent # Title Filing Date Issue Date Intl Class
8,906,413 Drug formulations having reduced abuse potentialMay 12, 03Dec 09, 14[A61K]
8,889,191 Sustained-release formulations of topiramateDec 17, 10Nov 18, 14[A61K, B82Y]
8,877,248 Sustained-release formulations of topiramateJul 14, 14Nov 04, 14[A61K]
8,821,930 Modified release preparations containing oxcarbazepine and derivatives thereofDec 11, 13Sep 02, 14[A61K]
8,808,714 Use of a mixture of two or more enteric materials to regulate drug release via membrane or matrix for systemic therapeuticsJan 10, 11Aug 19, 14[A61F, A61K]
8,747,897 Osmotic drug delivery systemApr 27, 06Jun 10, 14[A61K]
8,748,472 Stabilized formulations of CNS compoundsMar 30, 11Jun 10, 14[A61K]
8,709,476 Compositions of quaternary ammonium compounds containing bioavailability enhancersNov 04, 04Apr 29, 14[A61K]
8,709,478 Once daily formulations of tetracyclinesJun 18, 13Apr 29, 14[A61K]
8,663,683 Sustained-release formulations of topiramateAug 27, 12Mar 04, 14[A61P, A61K]

View all patents..

Expired/Abandoned/Withdrawn Patents

Patent # Title Filing Date Issue/Pub Date Intl Class
2014/0037,745 CONTROLLED RELEASE COMPOSITIONS OF GAMMA-HYDROXYBUTYRATESep 24, 13Feb 06, 14[A61K]
2013/0089,607 ONCE DAILY TROSPIUM CHLORIDE TREATMENT METHODSep 19, 12Apr 11, 13[A61K]
2011/0003,870 METHOD OF TREATMENT OF A NEUROLOGICAL DISORDERJun 30, 10Jan 06, 11[A61P, A61K]
2010/0221,352 PHARMACEUTICAL COMPOSITION FOR THE ONCE-A-DAY ORAL ADMINISTRATION OF TROSPIUM CHLORIDEMay 12, 10Sep 02, 10[A61P, A61K]
2010/0221,353 Pharmaceutical Composition For Once-A-Day Administration of Trospium ChlorideMay 12, 10Sep 02, 10[A61P, A61K]
2010/0221,354 PHARMACEUTICAL COMPOSITION FOR ONCE-A-DAY ORAL ADMINISTRATION OF TROSPIUM CHLORIDEMay 12, 10Sep 02, 10[A61P, A61K]
2010/0221,355 PHARMACEUTICAL COMPOSITION FOR ONCE-A-DAY ORAL ADMINISTRATION OF TROSPIUM CHLORIDEMay 12, 10Sep 02, 10[A61P, A61K]
2010/0221,356 PHARMACEUTICAL COMPOSITION FOR ONCE A DAY ADMINISTRATION OF TROSPIUM CHLORIDEMay 12, 10Sep 02, 10[A61P, A61K]
2010/0222,375 Pharmaceutical Composition Comprising Trospium Chloride for Once-A-Day AdministrationMay 12, 10Sep 02, 10[A61P, A61K]
2010/0209,489 Formulations of desvenlafaxineFeb 02, 10Aug 19, 10[A61P, A61K]
2010/0173,907 Method of treatment of aggressionDec 18, 09Jul 08, 10[A61P, A61K]
2010/0069,390 Method of treatment of attention deficit/hyperactivity disorder (ADHD)Sep 04, 09Mar 18, 10[A61P, A61K]
2009/0022,789 ENHANCED FORMULATIONS OF LAMOTRIGINEJul 18, 07Jan 22, 09[A61P, A61K]
2008/0131,501 Enhanced immediate release formulations of topiramateDec 04, 07Jun 05, 08[A61P, A61K]
2007/0249,537 ABSORPTION ENHANCING AGENTSApr 27, 07Oct 25, 07[A61P, A61K]
2007/0134,315 Orally administrable extended release pellet and tablet formulations of a highly water soluble compoundDec 08, 05Jun 14, 07[A61K]
2007/0104,782 Modified release tablet formulations with enhanced mechanical propertiesJul 28, 06May 10, 07[A61K]
2006/0210,625 Sustained release of positively charged pharmacologically active molecules from a matrix containing polymers with polarized oxygen atomsNov 04, 04Sep 21, 06[A61K]
2005/0191,343 Micellar systems useful for delivery of lipophilic or hydrophobic compoundsNov 24, 04Sep 01, 05[A61K]
2004/0202,693 Pharmaceutical compositions releasing their active agents from a buccal or sublingual location to overcome an absorption window problemApr 13, 04Oct 14, 04[A61K]

View all patents..

Top Inventors for This Owner

Upgrade to the Premium Level to View Top Inventors for this Owner. Learn More

We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!

We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.